ASXNotice of AGM & Proxy Form & Letter to Shareholders
other announcement
FRE
Pharmaceuticals, Biotechnology & Life Sciences
Firebrick Pharma
- Short interest
- 0.01%
- +0.01 pp 30d
- as of 1 July 2026
- Reported shorts
- 19.2K
- Shares on issue
- 285.199M
Firebrick Pharma (FRE) News
Latest articles and price-sensitive announcements with AI sentiment classification.
Firebrick Secures $732k in Strategic Investments
other announcement
Firebrick Investor Update Presentation
other announcement
StockheadHealth Check: Firebrick Pharma’s US pharmacy plans are nothing to sneeze at
Having sold its Nasodine spray-based anti-infective online in the US, Firebrick Pharma has decided to supply physical chemists. ... Read More The post Health Check: Firebrick Pharma’s US pharmacy plans are nothing to sneeze at appeared first on Stockhead.
Firebrick announces USA Retail Launch Plan
other announcement
Firebrick receives $293,000 R&D Tax Incentive
other announcement
Notice of AGM and Closing Date for Director Nominations
other announcement
Appendix 4E and Annual Report 30 June 2026
other announcement
Google NewsFirebrick Pharma (ASX:FRE): Inside the Nasodine Maker's Share Price Volatility - Kalkine
Firebrick Pharma (ASX:FRE): Inside the Nasodine Maker's Share Price Volatility Kalkine
Firebrick Pharma (ASX:FRE) Gains 14.29% as Nasodine Commercial Expansion Stays in View - Kalkine
Firebrick Pharma (ASX:FRE) Gains 14.29% as Nasodine Commercial Expansion Stays in View Kalkine
Update - Notification regarding unquoted securities - FRE
other announcement
ASX Biotech Stock Firebrick Pharma (ASX: FRE) Advances on Product Development Momentum - Kalkine
ASX Biotech Stock Firebrick Pharma (ASX: FRE) Advances on Product Development Momentum Kalkine
Nasodine Composition Patent Granted in New Zealand
other announcement
Change of Director's Interest Notice - Peter Molloy
director_dealing announcement
Change of Director's Interest Notice - Stephen Goodall
director_dealing announcement
March 2026 Quarterly Activity Report & Appendix 4C
other announcement
Firebrick Secures $1.5 million via Placement
capital_raise announcement
Registration Agreement and Approval of Nasodine in Indonesia
other announcement
Firebrick to present at NWR Virtual Healthcare Conference
other announcement
FRE appoints Head of Business Development and Licensing
other announcement